Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early cessation of N-acetylcysteine in low-risk paracetamol overdose
ACTRN12615000938505Phase 4Completed
- Sponsor
- Monash Health
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of acetylcysteine in acetaminophen poisoning (2 arms), sponsored by Monash Health. Primary endpoint: Hepatic injury. Started Feb 2016; status: completed.
02
Drugs
acetylcysteine
03
Conditions
acetaminophen poisoning
Beyond the preview
Go deeper on ACTRN12615000938505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000938505.